about
Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentationLearning and memory impairment in cocaine-dependent and comorbid schizophrenic patientsVolumetric analysis of the pre-frontal regions: findings in aging and schizophrenia.Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients.Brain metabolism in patients with schizophrenia before and after acute neuroleptic administrationA molecular basis of the therapeutic and psychoactive properties of cannabis (delta9-tetrahydrocannabinol).Imaging of thalamocortical dysrhythmia in neuropsychiatry.Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression.A review of the concept of the schizophrenic disorders.Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients.Subtyping of psychiatric disorders: implications for drug developmentPrediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging.Quantitative electrophysiological characteristics and subtyping of schizophrenia.Prolactin elevation with ziprasidone.Neuropsychiatric thalamocortical dysrhythmia: surgical implications.Low cerebellar metabolism in medicated patients with chronic schizophrenia.Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain.The introduction of neuroleptics: a psychiatric revolution.Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study.Medical and legal implications of side effects from neuroleptic drugs. A round-table discussionThe necessity of physiologic subtyping in schizophreniaIntroduction. Overview of citalopramRole of nondirective play therapy as a technic of psychotherapy in cerebral palsyClozapine-benzodiazepine interactionsPsychologic studies in geriatric hemiplegia
P50
Q28369585-7FC0A4D8-5CCD-41F2-92C2-542E2942316DQ28372074-83958271-A7F5-45D2-A6F2-BD126229E85DQ30659517-AFAF1776-B02A-4650-AB8F-D8E91221915EQ31440279-F52E055D-210E-47E2-94ED-63D09A4BC954Q33622735-16260753-3387-4D06-ABB7-3282D9B40CBFQ34790170-4EA89D87-9DDA-4AF1-BE8B-606E491BCA1FQ35144326-C1DD7397-4D2A-49AB-B72C-0EB03FA767F4Q35421990-4AC72C34-F181-4CF0-A8C7-D5993F70CFE6Q36264498-3FEC6950-C946-474A-AE71-15B77A5DB57BQ38418860-5FA3F081-17BA-4EBD-8A70-CA463F58CDBEQ38579347-6AD4A3EA-5053-462C-BF8F-14F5B418F202Q40382649-C2E9D6A4-BC24-47B6-B841-10CCA3FF995CQ44811754-9EA6BA6A-F7B7-4E15-8162-BE4B757F2AA7Q45091274-2D80E78C-36FB-40CF-8AC0-2F966DD9AAC8Q48255446-4C0BB8E7-51CE-49C3-8847-6D8DB5732D8BQ48486099-A0446389-9EFF-49D1-8BAE-BFFC4FC4931FQ48510719-332BD72D-0A2E-4EF1-B286-EC2A40D8993DQ48577159-AA848981-DB7B-44DC-8174-521AB7C5CB96Q49050186-495EEF85-8943-4A0F-B4CE-77424616AFE3Q51082710-6377E75A-0F3D-4952-9811-C46D6A0D9579Q52030953-84A85B2A-DDFC-4F3C-90D3-C27B21E8EDE3Q64786647-05E1F76E-E966-496F-B0CD-7B6C68E2B087Q68010262-4114FCB6-6739-4EDD-9FE4-9FCCCA1A6B7FQ73044405-E43A542C-3F34-40C2-A51B-5DF5F6C38877Q73788052-AC838BC2-ECF6-4984-85C5-97CDDF0EB4D0Q74113594-D045362A-0A73-4701-AE4C-04885D750CF0Q79062273-94E600CF-5E30-494E-817D-9C0339BBCC4D
P50
description
researcher ORCID ID = 0000-0003-1553-2168
@en
wetenschapper
@nl
name
Robert Cancro
@ast
Robert Cancro
@en
Robert Cancro
@es
Robert Cancro
@nl
type
label
Robert Cancro
@ast
Robert Cancro
@en
Robert Cancro
@es
Robert Cancro
@nl
prefLabel
Robert Cancro
@ast
Robert Cancro
@en
Robert Cancro
@es
Robert Cancro
@nl
P106
P31
P496
0000-0003-1553-2168